BioCryst Pharmaceuticals (BCRX)
(Delayed Data from NSDQ)
$8.11 USD
-0.04 (-0.49%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $8.11 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth A Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/7/24 |
---|---|
Current Quarter | -0.07 |
EPS Last Quarter | -0.06 |
Last EPS Surprise | 68.42% |
ABR | 1.36 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.38 |
Next Year | -0.20 |
EPS (TTM) | -0.70 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 114.78M | 115.00M | 434.66M | 506.73M |
# of Estimates | 3 | 4 | 3 | 4 |
High Estimate | 115.39M | 119.51M | 436.99M | 543.44M |
Low Estimate | 114.33M | 106.65M | 431.15M | 472.19M |
Year ago Sales | 86.74M | 93.40M | 331.41M | 434.66M |
Year over Year Growth Est. | 32.33% | 23.13% | 31.15% | 16.58% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.07 | -0.09 | -0.38 | -0.20 |
# of Estimates | 4 | 4 | 5 | 6 |
Most Recent Consensus | -0.03 | -0.03 | -0.30 | 0.15 |
High Estimate | -0.03 | -0.03 | -0.30 | 0.15 |
Low Estimate | -0.09 | -0.19 | -0.52 | -0.65 |
Year ago EPS | -0.19 | -0.28 | -1.00 | -0.38 |
Year over Year Growth Est. | 63.16% | 67.86% | 62.00% | 49.74% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 3 | 3 | 5 | 4 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.07 | -0.09 | -0.38 | -0.20 |
7 Days Ago | -0.07 | -0.09 | -0.38 | -0.20 |
30 Days Ago | -0.09 | -0.10 | -0.43 | -0.14 |
60 Days Ago | -0.14 | -0.14 | -0.63 | -0.27 |
90 Days Ago | -0.14 | -0.14 | -0.63 | -0.28 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.07 | -0.09 | -0.38 | -0.20 |
Zacks Consensus Estimate | -0.07 | -0.09 | -0.38 | -0.20 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.06 | -0.17 | -0.28 | -0.19 | NA |
Estimate | -0.19 | -0.23 | -0.24 | -0.25 | NA |
Difference | 0.13 | 0.06 | -0.04 | 0.06 | 0.05 |
Surprise | 68.42% | 26.09% | -16.67% | 24.00% | 25.46% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more